ArticleJACC. Case reports2025
Transapical Mitral Valve Implantation After Closure of Posterior Mitral Annulus Cavity With a Nitinol Occluder.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Expanding the Clinical Horizon of Transcatheter Interventions: Addressing the Complications of Endocarditis.JACC. Case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitral valve infective endocarditis involves a mitral annular abscess in approximately 15% of cases, and surgery is the treatment of choice for this scenario. An 80-year-old comorbid man with eradicated infective endocarditis had an emptied abscess cavity of the posterior mitral valve annulus (with left ventricular-left atrial connections) and had severe paravalvular and coexistent relevant transvalvular mitral regurgitation. He was not a surgical candidate. Successful management was with cavity closure, using a Nitinol occluder device, and transcatheter mitral valve implantation. This case demonstrates a novel transcatheter management approach to treat coexistent postendocarditis paravalvular and relevant transvalvular mitral regurgitation in a patient whose surgical risk was prohibitively high because of comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.